Health officials report rising concerns about patient safety as drug shortages continue, citing disruptions linked to supply chain problems related to the Iran war. According to the reports, shortages include painkillers, medications used to control blood pressure, and treatments for epilepsy. The outlets describe the situation as unusually severe, with some shortages characterized as among the worst that general practitioners and pharmacists have seen. Health chiefs say the ongoing lack of supply is increasing the risk that patients may be unable to obtain their usual medications or receive timely alternatives. The reporting focuses on the impact of the shortages on everyday treatment rather than on any single product or region. While the outlets emphasize patient safety concerns, they also indicate that authorities are monitoring the situation and considering the implications for prescribing and pharmacy supply. The coverage centers on the breadth of affected medicine categories—analgesics, cardiovascular drugs, and anti-seizure therapy—highlighting the potential for broader strain on routine care during the supply disruption.